Cees Neef

4.1k total citations
116 papers, 3.1k citations indexed

About

Cees Neef is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Oncology. According to data from OpenAlex, Cees Neef has authored 116 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pediatrics, Perinatology and Child Health, 25 papers in Pharmacology and 25 papers in Oncology. Recurrent topics in Cees Neef's work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Pharmaceutical studies and practices (20 papers) and Parkinson's Disease Mechanisms and Treatments (16 papers). Cees Neef is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (25 papers), Pharmaceutical studies and practices (20 papers) and Parkinson's Disease Mechanisms and Treatments (16 papers). Cees Neef collaborates with scholars based in Netherlands, United States and United Kingdom. Cees Neef's co-authors include Daan J. Touw, Teus van Laar, Hein A. W. van Onzenoort, Dirk K. F. Meijer, Alexander A. Vinks, Johannes H. Proost, Leo Stolk, David M. Burger, Sander Croes and Frank de Vries and has published in prestigious journals such as PLoS ONE, Neurology and Hypertension.

In The Last Decade

Cees Neef

116 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cees Neef Netherlands 32 477 476 475 473 392 116 3.1k
Elisabetta Poluzzi Italy 36 348 0.7× 606 1.3× 1.2k 2.6× 513 1.1× 153 0.4× 158 5.1k
Emanuel Raschi Italy 34 247 0.5× 566 1.2× 636 1.3× 659 1.4× 132 0.3× 169 4.1k
Eugène van Puijenbroek Netherlands 33 816 1.7× 1.0k 2.2× 313 0.7× 287 0.6× 141 0.4× 248 4.8k
Sebastian Harder Germany 34 203 0.4× 304 0.6× 402 0.8× 422 0.9× 143 0.4× 109 3.5k
Thierry Vial France 30 534 1.1× 337 0.7× 265 0.6× 406 0.9× 119 0.3× 175 3.6k
Haleh Bagheri France 31 373 0.8× 479 1.0× 207 0.4× 133 0.3× 459 1.2× 176 3.0k
Mathiéu Molimard France 47 435 0.9× 437 0.9× 1.0k 2.1× 690 1.5× 88 0.2× 250 7.9k
Concetta Rafaniello Italy 28 193 0.4× 286 0.6× 394 0.8× 438 0.9× 165 0.4× 98 2.2k
Annalisa Capuano Italy 41 547 1.1× 657 1.4× 1.1k 2.4× 821 1.7× 323 0.8× 266 5.8k
Patrick Blin France 30 186 0.4× 408 0.9× 258 0.5× 235 0.5× 114 0.3× 152 3.4k

Countries citing papers authored by Cees Neef

Since Specialization
Citations

This map shows the geographic impact of Cees Neef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cees Neef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cees Neef more than expected).

Fields of papers citing papers by Cees Neef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cees Neef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cees Neef. The network helps show where Cees Neef may publish in the future.

Co-authorship network of co-authors of Cees Neef

This figure shows the co-authorship network connecting the top 25 collaborators of Cees Neef. A scholar is included among the top collaborators of Cees Neef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cees Neef. Cees Neef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Driessen, Johanna H. M., Ronald M.A. Henry, Hein A. W. van Onzenoort, et al.. (2015). Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis. Calcified Tissue International. 97(2). 104–112. 64 indexed citations
4.
Croes, Sander, et al.. (2014). Vancomycin Dosing in Neutropenic Patients. PLoS ONE. 9(11). e112008–e112008. 22 indexed citations
5.
Kuypers, Aldy W.H.M., et al.. (2014). A Multilaboratory Commutability Evaluation of Proficiency Testing Material for Carbamazepine and Valproic Acid. Therapeutic Drug Monitoring. 37(4). 445–450. 3 indexed citations
6.
Driessen, Johanna H. M., Hein A. W. van Onzenoort, Ronald M.A. Henry, et al.. (2014). Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture. Bone. 68. 124–130. 58 indexed citations
7.
Leeuwen, Roelof W. F. van, Cees Neef, Teun van Gelder, et al.. (2013). Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs. British Journal of Cancer. 108(5). 1071–1078. 199 indexed citations
8.
Wong, Dennis R., Marieke Pierik, Margien L. Seinen, et al.. (2013). The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Journal of Crohn s and Colitis. 8(2). 120–128. 16 indexed citations
9.
Vries, Frank de, Jakob Starup‐Linde, Peter Vestergaard, et al.. (2013). Use of Biguanides and the Risk of Colorectal Cancer: A Register-Based Cohort Study. Current Drug Safety. 8(5). 349–356. 11 indexed citations
10.
11.
Movig, Kris L. L., Toine C. G. Egberts, P.J.E. Poels, et al.. (2009). Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease. European Journal of Clinical Pharmacology. 65(12). 1245–1251. 26 indexed citations
12.
Movig, Kris L. L., Henk‐Jan Guchelaar, P.J.E. Poels, et al.. (2008). Discontinuation of ropinirole and pramipexole in patients with Parkinson’s disease: clinical practice versus clinical trials. European Journal of Clinical Pharmacology. 64(10). 1021–1026. 9 indexed citations
13.
Pullen, Joyce, Leo Stolk, Pieter Degraeuwe, et al.. (2006). Pharmacokinetics of Intravenous Rifampicin (Rifampin) in Neonates. Therapeutic Drug Monitoring. 28(5). 654–661. 12 indexed citations
14.
Neef, Cees, et al.. (2006). Pitfalls in TDM of Antibiotic Drugs: Analytical and Modelling Issues. Therapeutic Drug Monitoring. 28(5). 686–689. 13 indexed citations
15.
Hoekstra, Monique, et al.. (2006). Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.. PubMed. 33(3). 481–5. 51 indexed citations
16.
Mulder, André B., et al.. (2001). Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin. Clinical Pharmacology & Therapeutics. 70(6). 546–551. 102 indexed citations
17.
18.
Burger, David M., Chris H.H. ten Napel, Jan W. Mulder, et al.. (1994). Pharmacokinetic variability of zidovudine in HIV-infected individuals. AIDS. 8(12). 1683–1690. 37 indexed citations
19.
Neef, Cees, et al.. (1988). An interaction between cytostatic and anticonvulsant drugs. Clinical Pharmacology & Therapeutics. 43(4). 372–375. 45 indexed citations
20.
Neef, Cees, et al.. (1983). CARRIER-MEDIATED TRANSPORT IN THE HANDLING OF DRUGS BY THE LIVER. Data Archiving and Networked Services (DANS). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabetta Poluzzi Breakdown of academic impact, for papers by Emanuel Raschi Breakdown of academic impact, for papers by Eugène van Puijenbroek Breakdown of academic impact, for papers by Sebastian Harder Breakdown of academic impact, for papers by Thierry Vial Breakdown of academic impact, for papers by Haleh Bagheri Breakdown of academic impact, for papers by Mathiéu Molimard Breakdown of academic impact, for papers by Concetta Rafaniello Breakdown of academic impact, for papers by Annalisa Capuano Breakdown of academic impact, for papers by Patrick Blin
Rankless by CCL
2026